教育程度是否会改变酒精使用与缺血性心脏病死亡率之间的关系? 来自英国生物银行的证据
Tara Martin1, Laura Llamosas-Falcón2, Yachen Zhu3
1Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5T 1R8, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College Street, M5T 1P8, Toronto, ON, Canada.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|February 18, 2026
概括
酒精消费和缺血性心脏病 (IHD) 死亡风险因英国男性的教育水平而异. 低教育程度可能会增加对酒精的脆弱性.
科学领域:
- 心血管流行病学心血管流行病学
- 公共卫生研究 公共卫生研究
- 健康的社会经济决定因素
背景情况:
- 酒精消费与缺血性心脏病 (IHD) 死亡率有关.
- 社会经济地位 (SES) 影响IHD负担和酒精对健康的影响.
- 教育成就是SES的一个关键指标.
研究的目的:
- 调查英国教育程度如何改变酒精使用与IHD死亡率之间的关联.
- 探索这种关系中的性别特异性差异.
主要方法:
- 使用英国生物银行数据对387914名当前饮酒者 (40-69岁) 的队列研究.
- 通过国家死亡登记册确定IHD死亡率.
- 考克斯比例危险模型分析了酒精使用,教育和IHD死亡风险.
主要成果:
- 较低的教育程度与较高的IHD死亡风险有关.
- 在男性中,中度饮酒 (>1-30g/天) 与偶尔饮酒相比,IHD死亡风险降低了39%.
- 在男性中观察到酒精使用和IHD死亡率与教育之间的差异关联,但在女性中没有.
结论:
- 酒精使用与IHD死亡风险之间的关系受男性教育程度的影响.
- 需要进一步的研究来了解酒精使用对IHD死亡率的性别和教育特异性风险.
相关概念视频
Hypothesis Test for Test of Independence
8.3K
The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
H0: The two variables (factors)...
8.3K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
291
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
291
Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K
Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease IV: Preventive Measures
741
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Atherosclerosis III: Management
465
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465

